The Week in Review: March 16 – March 23, 2018

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.

weekly_bull_sm

Friday, March 23, 2018

News Recap:

Northern Vancouver Island VIRAL HEPATITIS Outreach Roadshow Trip 2018 SlideShow.  Our team of volunteers has just return from a week of outreach on Vancouver Island’s north end, and we have put together few slideshows to tell you the story. There will be more images in the next few days, but check out what we have so far! A heartfelt thanks to Cheryl, Leon and Rosemary for doing this.

Novel score predicts DAA benefit in patients with HCV, decompensated cirrhosis. Researchers have developed a predictive score – the BE3A score – that quantifies the potential benefits of direct-acting antiviral therapy for patients with hepatitis C and decompensated cirrhosis. Five factors – BMI, hepatic encephalopathy, ascites, serum albumin and alanine aminotransferase levels – contribute to the novel BE3A score.

Herbal assault: liver toxicity of herbal and dietary supplements. The worldwide market for herbal and dietary supplements is booming.  But the health benefits of such products are largely unsubstantiated by scientific data, and they are increasingly associated with harmful side-effects, including liver toxicity.

Radio Interview with Daryl Luster of the Pacific Hepatitis C Network on the current situation where although drugs are now available to treat everyone with HepC in BC, the Federal government still refuses to listen to the experts and issue a mandate to Canadian physicians to automatically test Baby Boomers!! Listen to the interview here: http://cirh2.streamon.fm/listen-pl-15135